<table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 13. Established and Other Potentially Significant Drug Interactions</caption>
<col width="33%"></col>
<col width="21%"></col>
<col width="46%"></col>
<tbody>
<tr>
<td align="center" stylecode="     Botrule          Toprule         Lrule     "> <paragraph>
<content stylecode="bold">Concomitant Drug</content>
</paragraph>
</td>
<td align="center" stylecode="     Botrule          Toprule         Lrule     "> <paragraph>
<content stylecode="bold">Effect on Concentration of Lamotrigine or Concomitant Drug</content>
</paragraph>
</td>
<td align="center" stylecode="     Botrule          Toprule         Lrule          Rrule     "> <paragraph>
<content stylecode="bold">Clinical Comment</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Botrule         Lrule     "> <paragraph>Estrogen-containing oral contraceptive preparations containing 30 mcg ethinylestradiol and 150 mcg levonorgestrel</paragraph>
</td>
<td stylecode="     Botrule         Lrule     "> <paragraph>↓ lamotrigine <br/>
</paragraph>
<paragraph>↓ levonorgestrel</paragraph>
</td>
<td stylecode="     Botrule         Lrule          Rrule     "> <paragraph>Decreased lamotrigine concentrations approximately 50%. </paragraph>
<paragraph>Decrease in levonorgestrel component by 19%.</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Botrule         Lrule     "> <paragraph>Carbamazepine and carbamazepine epoxide</paragraph>
</td>
<td stylecode="     Botrule         Lrule     "> <paragraph>↓ lamotrigine </paragraph>
<paragraph>
<br/>? carbamazepine epoxide</paragraph>
</td>
<td stylecode="     Botrule         Lrule          Rrule     "> <paragraph>Addition of carbamazepine decreases lamotrigine concentration approximately 40%. </paragraph>
<paragraph>May increase carbamazepine epoxide levels. </paragraph>
</td>
</tr>
<tr>
<td stylecode="     Botrule         Lrule     "> <paragraph>Lopinavir/ritonavir</paragraph>
</td>
<td stylecode="     Botrule         Lrule     "> <paragraph>↓ lamotrigine</paragraph>
</td>
<td stylecode="     Botrule         Lrule          Rrule     "> <paragraph>Decreased lamotrigine concentration approximately 50%.</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Botrule         Lrule     "> <paragraph>Atazanavir/ritonavir</paragraph>
</td>
<td stylecode="     Botrule         Lrule     "> <paragraph>↓ lamotrigine</paragraph>
</td>
<td stylecode="     Botrule         Lrule          Rrule     "> <paragraph>Decreased lamotrigine AUC approximately 32%.</paragraph>
</td>
</tr>
<tr>
<td stylecode="     Botrule         Lrule     "> <paragraph>Phenobarbital/primidone </paragraph>
</td>
<td stylecode="     Botrule         Lrule     "> <paragraph>↓ lamotrigine </paragraph>
</td>
<td stylecode="     Botrule         Lrule          Rrule     "> <paragraph>Decreased lamotrigine concentration approximately 40%. </paragraph>
</td>
</tr>
<tr>
<td stylecode="     Botrule         Lrule     "> <paragraph>Phenytoin</paragraph>
</td>
<td stylecode="     Botrule         Lrule     "> <paragraph>↓ lamotrigine </paragraph>
</td>
<td stylecode="     Botrule         Lrule          Rrule     "> <paragraph>Decreased lamotrigine concentration approximately 40%. </paragraph>
</td>
</tr>
<tr>
<td stylecode="     Botrule         Lrule     "> <paragraph>Rifampin </paragraph>
</td>
<td stylecode="     Botrule         Lrule     "> <paragraph>↓ lamotrigine </paragraph>
</td>
<td stylecode="     Botrule         Lrule          Rrule     "> <paragraph>Decreased lamotrigine AUC approximately 40%. </paragraph>
</td>
</tr>
<tr>
<td stylecode="     Botrule         Lrule     "> <paragraph>Valproate </paragraph>
</td>
<td stylecode="     Botrule         Lrule     "> <paragraph>↑ lamotrigine </paragraph>
<paragraph>
<br/>? valproate </paragraph>
</td>
<td stylecode="     Botrule         Lrule          Rrule     "> <paragraph>Increased lamotrigine concentrations slightly more than 2 fold. </paragraph>
<paragraph>There are conflicting study results regarding effect of lamotrigine on valproate concentrations: 1) a mean 25% decrease in valproate concentrations in healthy volunteers, 2) no change in valproate concentrations in controlled clinical trials in patients with epilepsy.</paragraph>
</td>
</tr>
</tbody>
</table>